327 related articles for article (PubMed ID: 25822972)
1. The effect of iron ion on the specificity of photodynamic therapy with 5-aminolevulinic acid.
Hayashi M; Fukuhara H; Inoue K; Shuin T; Hagiya Y; Nakajima M; Tanaka T; Ogura S
PLoS One; 2015; 10(3):e0122351. PubMed ID: 25822972
[TBL] [Abstract][Full Text] [Related]
2. Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.
Nakanishi T; Ogawa T; Yanagihara C; Tamai I
J Pharm Sci; 2015 Sep; 104(9):3092-100. PubMed ID: 25959076
[TBL] [Abstract][Full Text] [Related]
3. Modulation and proteomic changes on the heme pathway following treatment with 5-aminolevulinic acid.
Sansaloni-Pastor S; Varesio E; Lange N
J Photochem Photobiol B; 2022 Aug; 233():112484. PubMed ID: 35671620
[TBL] [Abstract][Full Text] [Related]
4. Roles of porphyrin and iron metabolisms in the δ-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin and photodamage of tumor cells.
Ohgari Y; Miyata Y; Miyagi T; Gotoh S; Ohta T; Kataoka T; Furuyama K; Taketani S
Photochem Photobiol; 2011; 87(5):1138-45. PubMed ID: 21668870
[TBL] [Abstract][Full Text] [Related]
5. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA).
Rittenhouse-Diakun K; Van Leengoed H; Morgan J; Hryhorenko E; Paszkiewicz G; Whitaker JE; Oseroff AR
Photochem Photobiol; 1995 May; 61(5):523-8. PubMed ID: 7770514
[TBL] [Abstract][Full Text] [Related]
6. Metabolic characterization of tumor cell-specific protoporphyrin IX accumulation after exposure to 5-aminolevulinic acid in human colonic cells.
Krieg RC; Messmann H; Rauch J; Seeger S; Knuechel R
Photochem Photobiol; 2002 Nov; 76(5):518-25. PubMed ID: 12462647
[TBL] [Abstract][Full Text] [Related]
7. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
Schary N; Novak B; Kämper L; Yousf A; Lübbert H
Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
[TBL] [Abstract][Full Text] [Related]
8. Iron chelation promotes 5-aminolaevulinic acid-based photodynamic therapy against oral tongue squamous cell carcinoma.
Qin J; Zhou C; Zhu M; Shi S; Zhang L; Zhao Y; Li C; Wang Y; Wang Y
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101907. PubMed ID: 32619712
[TBL] [Abstract][Full Text] [Related]
9. Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.
Magnussen A; Reburn C; Perry A; Wood M; Curnow A
Lasers Med Sci; 2022 Mar; 37(2):1155-1166. PubMed ID: 34218351
[TBL] [Abstract][Full Text] [Related]
10. Polymeric iron chelators for enhancing 5-aminolevulinic acid-induced photodynamic therapy.
Nomoto T; Komoto K; Nagano T; Ishii T; Guo H; Honda Y; Ogura SI; Ishizuka M; Nishiyama N
Cancer Sci; 2023 Mar; 114(3):1086-1094. PubMed ID: 36341512
[TBL] [Abstract][Full Text] [Related]
11. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of ABCG2 transporter by lapatinib enhances 5-aminolevulinic acid-mediated protoporphyrin IX fluorescence and photodynamic therapy response in human glioma cell lines.
Mansi M; Howley R; Chandratre S; Chen B
Biochem Pharmacol; 2022 Jun; 200():115031. PubMed ID: 35390338
[TBL] [Abstract][Full Text] [Related]
13. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic study of PpIX accumulation using the JFCR39 cell panel revealed a role for dynamin 2-mediated exocytosis.
Kitajima Y; Ishii T; Kohda T; Ishizuka M; Yamazaki K; Nishimura Y; Tanaka T; Dan S; Nakajima M
Sci Rep; 2019 Jun; 9(1):8666. PubMed ID: 31209282
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the effect of 5-aminolevulinic acid-based photodynamic therapy by simultaneous hyperthermia.
Yanase S; Nomura J; Matsumura Y; Nagai K; Kinoshita M; Nakanishi H; Ohnishi Y; Tokuda T; Tagawa T
Int J Oncol; 2005 Jul; 27(1):193-201. PubMed ID: 15942660
[TBL] [Abstract][Full Text] [Related]
16. Aminolevulinic Acid-Based Tumor Detection and Therapy: Molecular Mechanisms and Strategies for Enhancement.
Yang X; Palasuberniam P; Kraus D; Chen B
Int J Mol Sci; 2015 Oct; 16(10):25865-80. PubMed ID: 26516850
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminolevulinic acid regulates the inflammatory response and alloimmune reaction.
Fujino M; Nishio Y; Ito H; Tanaka T; Li XK
Int Immunopharmacol; 2016 Aug; 37():71-78. PubMed ID: 26643355
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Renal Cell Carcinoma Cell Response to the Enhancement of 5-aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence by Iron Chelator Deferoxamine
Howley R; Mansi M; Shinde J; Restrepo J; Chen B
Photochem Photobiol; 2023 Mar; 99(2):787-792. PubMed ID: 35857390
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic anticancer activity evaluation of novel 5-aminolevulinic acid and 3-hydroxypyridinone conjugates.
Zhang J; Yuan S; Fan M; Wang K; Guo J; Zang A; Ren J; Su W; Zhang C; Xie Y
Bioorg Med Chem; 2024 May; 105():117726. PubMed ID: 38626642
[TBL] [Abstract][Full Text] [Related]
20. Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines.
Ji Z; Yang G; Vasovic V; Cunderlikova B; Suo Z; Nesland JM; Peng Q
J Photochem Photobiol B; 2006 Sep; 84(3):213-20. PubMed ID: 16709459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
